Literature DB >> 10486156

A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice.

C J Ong1, S Ip, S J Teh, C Wong, F R Jirik, M J Grusby, H S Teh.   

Abstract

Mice heterozygous for the tight-skin (Tsk) mutation develop skin fibrosis. Previous studies have implicated a role for the immune system and, specifically, CD4(+) T cells, in the etiology of skin fibrosis in Tsk/+ mice. We have recently shown that the administration of neutralizing anti-IL-4 antibodies to Tsk/+ mice prevented the development of skin fibrosis in these mice. Since IL-4 is a major cytokine produced by T helper 2 (Th2) cells, we investigated the role of Th2 cells in mediating skin fibrosis in Tsk/+ mice. Previous studies have shown that the development of Th2 cells in non-Tsk mice is abrogated in mice with null mutation for either the IL-4 or the Stat6 gene. In this study we showed that the polarization of CD4(+) T cells from Tsk/+ mice toward the Th2 lineage is also dependent on a functioning IL-4 or Stat6 gene. More importantly, the development of skin fibrosis in Tsk/+ mice was abrogated by the IL4(-/-) or the Stat6(-/-) mutation. We also determined whether alteration of the TCR repertoire in Tsk/+ mice, achieved by the introduction of TCR transgenes, was able to prevent the development of skin fibrosis in Tsk/+ mice. We found that the exclusive usage of the Vbeta8.2 gene segment by T cells was sufficient to prevent skin fibrosis in Tsk/+ mice. This result suggests that the exclusive use of this Vbeta gene segment by T cells may have prevented the development of fibrosis-causing Th2 cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486156     DOI: 10.1006/cimm.1999.1537

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  19 in total

Review 1.  The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide.

Authors:  S J Oliver
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

Review 2.  Intravenous immunoglobulin and fibrosis.

Authors:  Vered Molina; Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 3.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.

Authors:  Thomas A Wynn
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

4.  JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis.

Authors:  Jingyin Yan; Zhengmao Zhang; Jun Yang; William E Mitch; Yanlin Wang
Journal:  J Am Soc Nephrol       Date:  2015-06-01       Impact factor: 10.121

5.  B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.

Authors:  Minoru Hasegawa; Yasuhito Hamaguchi; Koichi Yanaba; Jean-David Bouaziz; Junji Uchida; Manabu Fujimoto; Takashi Matsushita; Yukiyo Matsushita; Mayuka Horikawa; Kazuhiro Komura; Kazuhiko Takehara; Shinichi Sato; Thomas F Tedder
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 6.  Animal models in scleroderma.

Authors:  Stephen H Clark
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

Review 7.  Molecular pathogenesis of skin fibrosis: insight from animal models.

Authors:  Gideon P Smith; Edwin S L Chan
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

Review 8.  Cellular and molecular mechanisms of fibrosis.

Authors:  T A Wynn
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

9.  Interleukin-13 is involved in the formation of liver fibrosis in Clonorchis sinensis-infected mice.

Authors:  Yanquan Xu; Pei Liang; Meng Bian; Wenjun Chen; Xiaoyun Wang; Jinsi Lin; Mei Shang; Hongling Qu; Zhongdao Wu; Yan Huang; Xinbing Yu
Journal:  Parasitol Res       Date:  2016-03-19       Impact factor: 2.289

10.  Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.

Authors:  Jennifer L Sargent; Zhenghui Li; Antonios O Aliprantis; Matthew Greenblatt; Raphael Lemaire; Ming-Hua Wu; Jun Wei; Jaclyn Taroni; Adam Harris; Kristen B Long; Chelsea Burgwin; Carol M Artlett; Elizabeth P Blankenhorn; Robert Lafyatis; John Varga; Stephen H Clark; Michael L Whitfield
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.